A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Histocompatibility Laboratory

Histocompatibility Laboratory
The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 1 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Patient Care Overview

City of Hope Locations

Cancer Care
For the 11th year, U.S.News & World Report has named City of Hope one of the top cancer hospitals in the country.
NEWS & UPDATES
  • Donating blood and platelets saves lives. We all know this. Yet every summer, potential blood donors become distracted by vacations and schedule changes. As a result, blood donations fall dramatically across the nation, leaving hospitals frantically trying to bring in much-needed blood for their patients. Earli...
  • To be a great cancer hospital, you need a great oncology program. Just ask City of Hope – and Becker’s Hospital Review. The health care publishing industry stalwart, described as the “leading hospital magazine for hospital business news and analysis for hospital and health system executives,” recently selected ...
  • Diagnostic errors are far from uncommon. In fact, a recent study found that they affect about 12 million people, or 1 in 20 patients,  in the U.S. each year. With cancer, those errors in diagnosis can have a profound impact. A missed or delayed diagnosis can make the disease that much harder to treat, as the Ag...
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...